UNSPSC 51382001: Bufexamac

This classification denotes a non-steroidal anti-inflammatory agent with the molecular formula C12H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4T3C38J78L, chemically known as benzeneacetamide, 4-butoxy-n-hydroxy- (9ci) but generally known as bufexamac, which bears US NIH Compound Identifier 2466. European Medicines Agency schedules Bufexamac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05961MIG.

UNSPSC 51382001 Bufexamac is a Commodity code that does not align with recent state and local procurement activity under this classification. Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually — neither of which are bufexamac products. Bufexamac is a topical anti-inflammatory agent used in dermatological preparations, while the Seminole County opportunity targets emergency response and harm-reduction pharmaceuticals and medical devices. The mismatch suggests either a coding error in how the opportunity was tagged or a fundamental disconnect between the UNSPSC classification and the goods actually being procured under this code in current state and local markets.

The source provides no additional recent opportunities under UNSPSC 51382001, making it impossible to assess whether this code sees meaningful activity across other state and local jurisdictions or issuing bodies. The single opportunity on record appears to be a data-tagging anomaly rather than a representative example of what state and local governments actually purchase when they use this Commodity code. For business development purposes, this code shows no actionable recent activity in state and local procurement.